CRISPR/Cas9-mediated genetic correction reverses spinocerebellar ataxia 3 disease-associated phenotypes in differentiated cerebellar neurons.

MLA

Song, Guoxu, et al. “CRISPR/Cas9-Mediated Genetic Correction Reverses Spinocerebellar Ataxia 3 Disease-Associated Phenotypes in Differentiated Cerebellar Neurons.” Life Medicine, vol. 1, no. 1, June 2022, pp. 27–44. EBSCOhost, https://doi.org/10.1093/lifemedi/lnac020.

APA

Song, G., Ma, Y., Gao, X., Zhang, X., Zhang, F., Tian, C., Hou, J., Liu, Z., Zhao, Z., & Tian, Y. (2022). CRISPR/Cas9-mediated genetic correction reverses spinocerebellar ataxia 3 disease-associated phenotypes in differentiated cerebellar neurons. Life Medicine, 1(1), 27–44. https://doi.org/10.1093/lifemedi/lnac020

Chicago

Song, Guoxu, Yuying Ma, Xing Gao, Xuewen Zhang, Fei Zhang, Chunhong Tian, Jiajia Hou, Zheng Liu, Zixin Zhao, and Yong Tian. 2022. “CRISPR/Cas9-Mediated Genetic Correction Reverses Spinocerebellar Ataxia 3 Disease-Associated Phenotypes in Differentiated Cerebellar Neurons.” Life Medicine 1 (1): 27–44. doi:10.1093/lifemedi/lnac020.